Effects of Antihypertensive Medications on All-cause Dementia: Evidence from Target Trial Emulation of 3 Million US Veterans

被引：0
|
作者：
Xu, Yizhe
Derington, Catherine
Greene, Tom
Scharfstein, Daniel
Andrews, Ryan
Berchie, Ransmond
Zhang, Chong
Supiano, Mark
Williamson, Jeff
Pajewski, Nicholas
Pruzin, Jeremy
Shulman, Rachel
Cohen, Jordana
Bress, Adam
机构：
来源：
HYPERTENSION | 2024年 / 81卷
关键词：
D O I：
10.1161/hyp.81.suppl_1.P134
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P134
引用
收藏
页数：2
相关论文
共 28 条
  • [1] Causal effect of shifting from precarious to standard employment on all-cause mortality in Sweden: an emulation of a target trial
    Matilla-Santander, Nuria
    Matthews, Anthony A.
    Gunn, Virginia
    Muntaner, Carles
    Kreshpaj, Bertina
    Wegman, David H.
    Sanchez-Martinez, Nestor
    Hernando-Rodriguez, Julio C.
    Albin, Maria
    Balogh, Rebeka
    Davis, Letitia
    Bodin, Theo
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2023, 77 (11) : 736 - 743
  • [2] Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study
    Aguado, Jaume
    Gutierrez, Lia
    Forns, Joan
    Vila-Guilera, Julia
    Rothman, Kenneth J.
    Garcia-Albeniz, Xabier
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2025, 194 (03) : 691 - 698
  • [3] Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: A target trial emulation study
    Aguado, Jaume
    Gutierrez, Lia
    Rothman, Kenneth
    de Albeniz, Xabier Garcia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 43 - 43
  • [4] Trends in All-cause Mortality Among US Veterans With Sarcoidosis From 2004-2022
    Seedahmed, M. I.
    Albirair, M. T.
    Baugh, A. D.
    Gellad, W. F.
    Whooley, M. A.
    McCulloch, C. E.
    Koth, L. L.
    Arjomandi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Effectiveness of treat-to-target cholesterol-lowering interventions on cardiovascular disease and all-cause mortality risk in the community-dwelling population: a target trial emulation
    Yang, Zhao
    Deng, Qiujv
    Hao, Yongchen
    Yang, Na
    Han, Lizhen
    Jia, Pingping
    Zhou, Pan
    Hao, Yiming
    Wang, Ziyu
    Zhao, Wenlang
    Qi, Yue
    Liu, Jing
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Lack of Evidence for Racial Disparity in 30-Day All-Cause Readmission Rate for Older US Veterans Hospitalized with Heart Failure
    Kheirbek, Raya Elfadel
    Wojtusiak, Janusz
    Vlaicu, Sorina O.
    Alemi, Farrokh
    QUALITY MANAGEMENT IN HEALTH CARE, 2016, 25 (04) : 191 - 196
  • [7] Emerging Sitagliptin Benefit for All-Cause Hospitalizations: Evidence from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    Reed, Shelby D.
    Li, Yanhong
    Leal, Jose
    Graham, Felicia
    Alfredsson, Joakim
    Gray, Alastair M.
    Buse, John B.
    Green, Jennifer B.
    Kaufman, Keith D.
    Riefflin, Axel
    Suryawanshi, Shailaja
    Van de Werf, Frans
    Peterson, Eric D.
    Holman, Rury R.
    DIABETES, 2017, 66 : A360 - A360
  • [8] The impact of oxidative balance on all-cause and cause-specific mortality in US adults and cancer survivors: evidence from NHANES 2001-2018
    Wu, Juan
    Han, Yingdong
    Yao, Menghui
    Zhao, He
    Li, Zhikai
    Xie, Tiange
    Zhang, Yun
    Zeng, Xuejun
    BMC CANCER, 2025, 25 (01)
  • [9] Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Ho, Chau
    Bresliln, Monique
    Chowdhury, Enayet
    Doust, Jenny
    Reid, Christopher M.
    Davis, Barry R.
    Simpson, Lara M.
    Nelson, Mark R.
    CIRCULATION, 2019, 140
  • [10] Oral microbiome alpha diversity and all-cause, cardiovascular, and non-cardiovascular mortality in US adults: Evidence from the NHANES 2009-2019
    Mondal, Rajib
    Ritu, Rani Baroi
    Kitaoka, Kaori
    Azahar, Nazar Mohd
    Moniruzzaman, Mohammad
    Ogata, Soshiro
    Kiyoshige, Eri
    Tohara, Haruka
    Kobayashi, Yusuke
    Kashihara, Naoki
    Naito, Toshio
    Nakashima, Naoki
    Tamura, Kosuke
    Nishimura, Kunihiro
    Viera, Anthony J.
    Yano, Yuichiro
    ATHEROSCLEROSIS, 2025, 401
123